Drug ID: | NPD1913 |
Drug Name: | AAD-2004 |
Molecular Formula: | C16H14F3NO3 |
Canonical SMILES: | OC(=O)c1cc(NCCc2ccc(cc2)C(F)(F)F)ccc1O |
Standard InCHI: | InChI=1S/C16H14F3NO3/c17-16(18,19)11-3-1-10(2-4-11)7-8-20-12-5-6-14(21)13(9-12)15(22)23/h1-6,9,20-21H,7-8H2,(H,22,23) |
Standard InCHIKey: | UTMVACIBQLDZLP-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB014904 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 325.09 |
ALogP | 0.2448 |
MLogP | 2.45 |
XLogP | 5.582 |
HDA | 3 |
HBD | 3 |
Rotatable Bonds | 11 |
TPSA | 69.56 |
RO5 Violation | 1 |